You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Suppliers and packages for generic ingredient: EVEROLIMUS


✉ Email this page to a colleague

« Back to Dashboard


EVEROLIMUS

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novartis Pharm AFINITOR DISPERZ everolimus TABLET, FOR SUSPENSION;ORAL 203985 NDA Novartis Pharmaceuticals Corporation 0078-0626-51 28 BLISTER PACK in 1 CARTON (0078-0626-51) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (0078-0626-61) 2012-08-29
Novartis Pharm AFINITOR DISPERZ everolimus TABLET, FOR SUSPENSION;ORAL 203985 NDA Novartis Pharmaceuticals Corporation 0078-0627-51 28 BLISTER PACK in 1 CARTON (0078-0627-51) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (0078-0627-61) 2012-08-29
Novartis Pharm AFINITOR DISPERZ everolimus TABLET, FOR SUSPENSION;ORAL 203985 NDA Novartis Pharmaceuticals Corporation 0078-0628-51 28 BLISTER PACK in 1 CARTON (0078-0628-51) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (0078-0628-61) 2012-08-29
Mylan EVEROLIMUS everolimus TABLET, FOR SUSPENSION;ORAL 210130 ANDA Mylan Pharmaceuticals Inc. 0378-0005-85 4 BLISTER PACK in 1 CARTON (0378-0005-85) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK 2021-10-01
Mylan EVEROLIMUS everolimus TABLET, FOR SUSPENSION;ORAL 210130 ANDA Mylan Pharmaceuticals Inc. 0378-0006-85 4 BLISTER PACK in 1 CARTON (0378-0006-85) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK 2021-10-01
Mylan EVEROLIMUS everolimus TABLET, FOR SUSPENSION;ORAL 210130 ANDA Mylan Pharmaceuticals Inc. 0378-0007-85 4 BLISTER PACK in 1 CARTON (0378-0007-85) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK 2021-10-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing